ArticleEJHaem2021
The ClpP activator ONC-212 (TR-31) inhibits BCL2 and B-cell receptor signaling in CLL.
Narjis Fatima et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
5 papers cite it
this papercites it
ArticleEJHaem2021
Narjis Fatima et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.